Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      SKINCEUTICALS INTRODUCES TWO NEXT-GENERATION SKINCARE INNOVATIONS: TNXA-SHOT AND PHYTO CORRECTIVE PDRN SERUM

      Courtesy of SkinCeuticals

      News provided by

      SkinCeuticals

      Nov 17, 2026, 09:06 ET

      Share this article

      Share this article


      The Medical Aesthetic Skincare Brand Advances Its Corrective, Procedure-Complementary Portfolio with a Persistent Dark Spot Correcting Serum and PDRN Serum for Glowing Skin

      NEW YORK, Nov. 17, 2026 /PRNewswire/ -- SkinCeuticals, the #1 Medical Aesthetic Skincare Brand¹, today announces the launch of TNXA-Shot and Phyto Corrective PDRN Serum, two breakthrough innovations that advance the brand's corrective skincare portfolio with targeted solutions designed to complement in-office procedures for distinct skin concerns.

      CORRECT PERSISTENT DARK SPOTS IN ONE SHOT: INTRODUCING TNXA-SHOT

      TNXA-Shot is an advanced brightening serum clinically proven to reduce the look of persistent dark spots and discoloration that can resist laser treatments alone2. This multi-modal serum offers triple power against persistent dark spots caused by environmental, inflammatory and hormonal triggers, clinically proven to reduce dark spot size (-30%) and color intensity (-30%), with 93% of users showing maintained dark spot improvement over a 12-week period followed by a 2-week regression3. TNXA- Shot is formulated with 5% Tranexamic Acid, 1% Alpha-Amino Acid derivative, and 3% Dandelion Root Extract to target and reduce the look of persistent discoloration by up to -20%. TNXA-Shot will replace the brand's existing Discoloration Defense serum.

      "Persistent discoloration can be particularly challenging to address because it can involve multiple underlying triggers," said Dr. Corey L. Hartman, MD, FAAD. " Rather than relying on a single brightening mechanism, TNXA-Shot approaches discoloration via a multi-pathway approach, combining several targeted ingredients to address the complex nature of discoloration while complementing the benefits of laser treatments."

      TNXA Shot at a Glance

      • Triple Power Against Persistent Dark Spots: Clinically tested to target size, color and staying power3
      • Patent-Pending Advanced Brightening Complex: 5% Tranexamic Acid, 1% Alpha Amino Acid derivative and 3% Dandelion Root Extract
      • Multi-Pathway Discoloration Technology: 4% Niacinamide, 0.15% SymWhite, 0.15% LHA and 0.2% Carnosine
      • Clinically Proven: Visibly reduces discoloration by up to 20%.
      • Laser Complement: Physician-tested to complement laser treatments.
      • Targets Multiple Concerns: Helps address the appearance of dark spots, sun spots, brown patches, post-inflammatory hyperpigmentation (PIH), and post-inflammatory erythema (PIE).
      • Lightweight Finish: New lightweight emulsion texture designed for daily use.
      • Thoughtfully Formulated: TNXA-Shot is formulated for all skin types and skin tones. Paraben-free, hydroquinone-free, hypoallergenic fragrance.

      TNXA Shot FAQ

      What is TNXA-Shot?
      TNXA-Shot is an advanced brightening serum designed to visibly reduce the appearance of persistent dark spots and discoloration, including discoloration that can resist laser treatment alone2, ultimately promoting a brighter, more even-toned complexion.

      What makes TNXA-Shot different from the previous Discoloration Defense serum?
      Skin discoloration occurs when environmental or physiological factors, such as UV exposure, inflammation, or hormonal fluctuations, disrupt the skin's natural pigment-regulating processes, leading to uneven tone and areas of hyperpigmentation. TNXA-Shot replaces Discoloration Defense with an advanced, multi-modal formula featuring 5% Tranexamic Acid and a new Advanced Complex designed to target these triggers of discoloration, delivered in a new lightweight emulsion serum.

      Who is this Product for?

      TNXA-Shot is best for individuals struggling with persistent dark spots or total skin discoloration, stemming from environmental, hormonal or inflammatory factors. TNXA-Shot offers a new advanced complex of Tranexamic Acid, Alpha-Amino Acid derivative, and Dandelion Root Extract to help address persistent discoloration, with triple power against dark spots, clinically proven to target size, color, and staying power, preventing their recurrence for up to 2 weeks3.

      Can TNXA-Shot be used with laser treatments?
      Yes. TNXA Shot is physician-tested to complement laser treatments. Persistent discoloration can resist laser treatment and may recur after treatment, so a comprehensive approach including topical skincare, sun protection and professional treatment is often advised.

      What are the key ingredients in TNXA-Shot?
      Key ingredients include 5% Tranexamic Acid, 1% Alpha Amino Acid derivative, 3% Dandelion Root Extract, 4% Niacinamide, SymWhite, LHA and Carnosine.

      PIONEERING THE NEXT GENERATION OF PDRN: PHYTO CORRECTIVE PDRN SERUM

      Get glowing with Phyto Corrective PDRN Serum, a clinically backed, next-generation PDRN serum formulated for sensitive skin prone to dullness and redness. A first-of-its kind innovation for L'Oreal USA's Dermatological Beauty Division, this formula features exclusive biotech PDRN, a non-animal-derived ingredient made from 100% DNA + RNA with up to 99% similarity to human DNA in GC (Guanine-Cytosine) content, it is optimized for effective skin absorption to promote barrier repair, reduce visible skin redness, and visibly improve skin quality for a healthier-looking complexion and a radiant, luminous glow. It will replace the existing Phyto Corrective Gel.

      "Phyto Corrective PDRN Serum is particularly innovative because it brings the emerging science of biotech PDRN into a topical skincare formula, pairing it with proven soothing and barrier-supporting ingredients," said Dr. Lisa R. Ginn, MD, FAAD. "It's an exciting advancement for patients who want to improve the look and feel of sensitive skin while supporting its ability to recover."

      Phyto Corrective PDRN Serum at a Glance

      • Next-Generation PDRN: Features exclusive 0.13% biotech PDRN, a non-animal derived PDRN made from 100% DNA + RNA with up to 99% similarity to human DNA in GC (Guanine-Cytosine) content for optimal absorption. Extracted from Lactobacillus sakei thought an 18-step purification process.
      • Visible Skin Quality Repair: Designed to visibly enhance radiance, improve skin texture and reduce redness.
      • Clinically Proven: Immediately, 92% agree skin has a healthy-looking glow. In 1 hour, +40% better skin barrier recovery. In 8 weeks, up to +25% improvement in radiance, +25% improvement in skin texture, and -20% reduction in visible redness⁴.
      • Soothing Phyto Technology: 8% Phyto Botanical Blend featuring grapefruit, cucumber, thyme, olive leaf, rosemary and mulberry extracts.
      • Barrier Support: Ectoin and Tripeptide-8 help soothe and strengthen the skin barrier.
      • 48-Hour Hydration: A 9.7% Hydrating Complex helps provide up to 48 hours of hydration.
      • Post-Procedure Tested: Physician-tested following microneedling, lasers and chemical peels.
      • Suitable for All Skin Types.

      Phyto Corrective PDRN Serum FAQs

      What is Phyto Corrective PDRN Serum?
      Phyto Corrective PDRN Serum is a next-generation PDRN serum for visible skin quality improvement and a radiant, luminous glow, designed for sensitive skin prone to dullness and redness.

      What is biotech PDRN?
      SkinCeuticals' exclusive biotech PDRN is a non-animal-derived PDRN extracted from Lactobacillus sakei through an 18-step purification process. It is made from 100% DNA + RNA and is optimized for effective skin absorption to promote skin barrier repair, reduce visible skin redness, and visibly improve skin quality for a healthier-looking complexion and a radiant, luminous glow.

      What does Phyto Corrective PDRN Serum do?
      The serum promotes barrier repair and total skin hydration, visibly improving skin quality for a radiant, luminous glow, and reduced visible skin redness.

      Who is this Product for?

      Phyto Corrective PDRN is best for individuals struggling with dull, textured, or redness-prone skin. With calming botanicals, soothing tripeptide-8, and a hydrating complex of hyaluronic acid and glycerin, it helps soothe sensitivity, reduce visible redness, and visibly improves skin quality for a healthier-looking complexion and a radiant, luminous glow.

      Can Phyto Corrective PDRN Serum be used after aesthetic procedures?
      Yes, it can be used within 24H following procedure, at the recommendation of a professional. The formula is physician-tested for post-procedure use following microneedling, lasers and chemical peels.

      AVAILABILITY & PRICING

      TNXA-Shot will be available beginning November 17, 2026 for $120 on SkinCeuticals.com and through authorized skincare professionals nationwide.

      Phyto Corrective PDRN Serum will be available beginning November 17, 2026 for $90 on SkinCeuticals.com and through authorized skincare professionals nationwide.

      For more information, visit SkinCeuticals.com.

      ABOUT SKINCEUTICALS

      Founded on the groundbreaking antioxidant research of Dr. Sheldon Pinnell, SkinCeuticals has been at the forefront of advanced skincare innovation for nearly three decades. Established in Dallas, Texas in 1997, the brand discovers, develops and delivers scientifically backed skincare products designed to improve skin health. SkinCeuticals' integrated skincare approach is clinically proven to complement aesthetic procedures and optimize results.

      Trusted by dermatologists, plastic surgeons and aesthetic providers worldwide, SkinCeuticals is available through professional skincare practices globally.

      1. Based on dermatologist recommendation data on file.

      2. Disclaimer: Persistent discoloration can resist laser treatment and can reoccur after treatment.  For long term improvement, a comprehensive approach including topicals, sun protection, and laser treatment is often advised.

      3. After 12 weeks of twice daily use, following 2 weeks of product discontinuation, 93% of subjects maintained improvement in at least one of the size or contrast of a persistent dark spot, as assessed by expert grading. 30% represents the top quarter of responders for size and intensity, 22% represents the average result across 59 subjects.

      4. Clinical testing of 78 subjects after 8 weeks showed -20% look of redness across a subgroup of 55 subjects, -25% texture improvement among top 33% responders and -24% texture improvement across all 78 subjects, -20% visible post-blemish marks among top 33% responders and -10% visible post-blemish marks across all 78 subjects

       [email protected]

      SOURCE SkinCeuticals

      Modal title

      Also from this source

      SKINCEUTICALS INTRODUCES THE NEXT GENERATION OF C E FERULIC: THE ICONIC ANTIOXIDANT SERUM, NOW PROVEN TO VISIBLY REVERSE UP TO 10 YEARS OF AGING SIGNS

      SKINCEUTICALS INTRODUCES THE NEXT GENERATION OF C E FERULIC: THE ICONIC ANTIOXIDANT SERUM, NOW PROVEN TO VISIBLY REVERSE UP TO 10 YEARS OF AGING SIGNS

      SkinCeuticals, the #1 Medical Aesthetic Skincare Brand¹ and creator of the antioxidant serum category, today announces the next generation of C E...

      SKINCEUTICALS ANNOUNCES ALI LARTER AS BRAND AMBASSADOR

      SKINCEUTICALS ANNOUNCES ALI LARTER AS BRAND AMBASSADOR

      SkinCeuticals, the #1 medical aesthetic skincare brand worldwide, is thrilled to announce actress and producer Ali Larter as its newest brand...

      More Releases From This Source

      Explore

      Cosmetics and Personal Care

      Cosmetics and Personal Care

      Household, Consumer & Cosmetics

      Household, Consumer & Cosmetics

      Medical Pharmaceuticals

      Medical Pharmaceuticals

      Health Care & Hospitals

      Health Care & Hospitals

      News Releases in Similar Topics

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.